Overcoming challenges hindering potency within the TME to enhance efficacy of cell therapies for solid tumors
15 Apr 2025
Cell Therapy Development
- Can we modulate the immunosuppressive tumor microenvironment effectively?
- Can we engineer resilient cell therapies for TME?
- Are combination approaches with synergistic effects a possible path forward?
- Can we leverage biomarkers and patient selection in combination with preclinical models to improve current therapies?
Industry Expert
